Biochemical mechanisms of HIV induced T cell apoptosis

Cell Death and Differentiation

Volumn 8, Issue 2, 2001, Pages 127-136

  Selliah, N ^a   Finkel, T H ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; HIV; Immunity

Indexed keywords

ANTIRETROVIRUS AGENT; CASPASE 8; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; GENE PRODUCT; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 2; JANUS KINASE; NEF PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN BCL 2; PROTEIN P56; PROTEIN TYROSINE PHOSPHATASE; PROTEINASE; PROTEINASE INHIBITOR; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNINDEXED DRUG; VIF PROTEIN; VIRUS DNA; VIRUS ENZYME; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; APOPTOSIS; BIOCHEMISTRY; CELL DEATH; CELL KILLING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC ANALYSIS; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE ACTIVATION; VIRAL GENETICS; VIRUS IMMUNITY; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GENE PRODUCTS, TAT; GENE PRODUCTS, VPR; HIV-1; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES; TUMOR SUPPRESSOR PROTEIN P53;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; JANUS;

EID: 0035093156     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400822     Document Type: Review

References (140)

1. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection
2. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection
3. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR
4. New concepts in the immunopathogenesis of human immunodeficiency virus infection
5. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
6. Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals
7. Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression
8. Apoptosis of CD4+ and CD8+ T cells isolated immediately ex vivo correlates with disease severity in human immunodeficiency virus type 1 infection
9. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans [see comments]
10. Limited CD4+ T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy
11. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas [see comments]
12. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
13. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation [see comments]
14. Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease
15. Does HIV cause depletion of CD4+ T cells in vivo by the induction of apoptosis?
16. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: Differential ligation constantly induces apoptosis
17. Fas (CD95) expression on CD4+ T cells from HIV-infected patients increases with disease progression
18. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals
19. Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing
20. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp 120
21. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by upregulating FLICE/caspase-8
22. Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway
23. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: Effects on NF-kappaB, activator protein-1, c-Jun N-terminal kinase, and apoptosis [In Process Citation]
24. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore
25. Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers [see comments]
26. High levels of HIV-1 replication show a clear correlation with downmodulation of Bcl-2 protein in peripheral blood lymphocytes of HIV-1-seropositive subjects
27. Downregulation of Bcl-2, but not of Bax or Bcl-x, is associated with T lymphocyte apoptosis in HIV infection and restored by antiretroviral therapy or by interleukin 2
28. Expression of human immunodeficiency virus type 1 tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells
29. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2
30. A cellular anti-apoptosis protein is cleaved by the HIV-1 protease
31. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells
32. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL
33. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents
34. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
35. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin
36. Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A
37. A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G(1) cell cycle arrest
38. Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation
39. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS [see comments]
40. Frequency of provirus-bearing CD4+ cells in HIV type 1 infection correlates with extent of in vitro apoptosis of CD8+ but not of CD4+ cells
41. Presence of CD3+CD8+Bcl-2(low) lymphocytes undergoing apoptosis and activated macrophages in lymph nodes of HIV-1 + patients
42. Apoptosis in HIV-1 Infection
43. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes [see comments]
44. Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection
45. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells
46. Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells
47. HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells
48. Lck-independent inhibition of T cell antigen response by the HIV gp 120
49. Effects of human immunodeficiency virus type 1 on CD4 lymphocyte subset activation
50. Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp 120)
51. Caspases cleave focal adhesion kinase during apoptosis to generate a FRNK-like polypeptide
52. Cleavage of focal adhesion kinase by caspases during apoptosis
53. Interleukin-1 beta converting enzyme-like protease involvement in Fas- induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation- death in HIV infection
54. Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors
55. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c
56. Modulation of Bcl-2 protein by CD4 cross-linking: A possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2
57. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: Correlation with its ability to block culture-induced down- modulation of Bcl-2
58. Cutting edge: JAK3 activation and rescue of T cells from HIV gp120- induced unresponsiveness
59. Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: Comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice
60. T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis
61. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells
62. STATs and gene regulation
63. Jaks, STATs, cytokine signal transduction and immunoregulation: Are we there yet?
64. HIV-1 infection induces a selective reduction in STAT5 protein expression
65. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein
66. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
67. Dual role of HIV Tat in regulation of apoptosis in T cells
68. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): A possible mechanism for Tat's immunosuppressive activity
69. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis
70. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression
71. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp 120 with chemokine receptor CXCR4 [see comments]
72. Viral proteins that regulate cellular signaling
73. Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection
74. The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication
75. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [see comments]
76. Human immunodeficiency virus type 1 Nef and p561ck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail
77. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor
78. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4
79. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif
80. HIV1 Nef: The Machiavelli of cellular activation
81. Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity
82. The T-cell receptor zeta chain contains two homologous domains with which simian immunodeficiency virus Nef interacts and mediates down-modulation
83. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines
84. Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T cell apoptosis
85. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain
86. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein
87. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
88. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1
89. Loss of G(1)/ S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1 [In Process Citation]
90. The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: Possible implications for the pathogenesis of AIDS
91. Mapping of HIV-1 determinants of apoptosis in infected T cells
92. The cell death-inducing ability of glycoprotein 120 from different HIV strains correlates with their ability to induce CD4 lateral association with CD95 on CD4+ T cells
93. JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3 kinase
94. CD8 naive T cell counts decrease progressively in HIV-infected adults
95. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation [see comments]
96. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies [see comments]
97. Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects
98. Immune reconstitution in HIV infection
99. Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patients
100. Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART
101. Concomitant therapy with subcutaneous interleukin-2 and zidovudine plus didanosine in patients with early stage HIV infection
102. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study [see comments]
103. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti- retroviral therapy [see comments]
104. Dynamics of provirus load and lymphocyte subsets after interleukin 2 treatment in HIV-infected patients
105. Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression
106. Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death
107. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor- alpha secretion
108. Productive infection and subsequent interaction of CD4-gp 120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells
109. Membrane alterations linked to early interactions of HIV with the cell surface
110. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1
111. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV
112. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells [published erratum appears in J Biol Chem 1995 Dec 1;270(48):29038]
113. Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway
114. Pathogenesis of human immunodeficiency virus infection
115. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes
116. Role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases
117. Activation of complement on the surface of cells infected by human immunodeficiency virus
118. Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1
119. Apoptosis induced by HIV infection in H9 T cells is blocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist
120. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
121. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection
122. gp 120-induced programmed cell death in recently activated T cells without subsequent ligation of the T cell receptor
123. Crosslinking CD4 by human immunodeficiency virus gp 120 primes T cells for activation-induced apoptosis
124. IL-12 inhibits apoptosis induced in a human Th1 clone by gp 120/ CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation
125. T-cell-mediated immunopathology versus direct cytolysis by virus: Implications for HIV and AIDS
126. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis
127. T cell telomere length in HIV-1 infection: No evidence for increased CD4+ T cell turnover
128. T helper type 1/T helper type 2 cytokines and T cell death: Preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons
129. Constitutive expression of HIV-1 tat protein in human Jurkat T cells using a BK virus vector
130. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis
131. Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection
132. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1
133. Repression of MHC class I gene promoter activity by two-exon Tat of HIV
134. The human immunodeficiency virus type-1 Tat protein upregulates Bc1-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells
135. Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects
136. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4
137. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2+M phase of the cell cycle
138. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection
139. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [see comments]
140. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B